Article
Cantor Fitzgerald Maintains Neutral on Amgen, Raises Price Target to $350
Cantor Fitzgerald analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $315 to $350.
Comments
- No comments yet. Be the first to comment!